ATE140540T1 - Verfahren zur zurichtung eines verbesserten western-blott-immuntestverfahrens - Google Patents
Verfahren zur zurichtung eines verbesserten western-blott-immuntestverfahrensInfo
- Publication number
- ATE140540T1 ATE140540T1 AT90108710T AT90108710T ATE140540T1 AT E140540 T1 ATE140540 T1 AT E140540T1 AT 90108710 T AT90108710 T AT 90108710T AT 90108710 T AT90108710 T AT 90108710T AT E140540 T1 ATE140540 T1 AT E140540T1
- Authority
- AT
- Austria
- Prior art keywords
- preparing
- immune test
- hiv
- test method
- western blott
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000010998 test method Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000001962 electrophoresis Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/22—Viral peptide or viral protein
- Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Electrochemistry (AREA)
- Peptides Or Proteins (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35018089A | 1989-05-09 | 1989-05-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE140540T1 true ATE140540T1 (de) | 1996-08-15 |
Family
ID=23375548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90108710T ATE140540T1 (de) | 1989-05-09 | 1990-05-09 | Verfahren zur zurichtung eines verbesserten western-blott-immuntestverfahrens |
Country Status (9)
Country | Link |
---|---|
US (1) | US5356772A (de) |
EP (1) | EP0397129B1 (de) |
JP (1) | JP2945074B2 (de) |
KR (1) | KR900018680A (de) |
AT (1) | ATE140540T1 (de) |
AU (1) | AU637097B2 (de) |
CA (1) | CA2016313C (de) |
DE (1) | DE69027812T2 (de) |
ES (1) | ES2091777T3 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5120662A (en) * | 1989-05-09 | 1992-06-09 | Abbott Laboratories | Multilayer solid phase immunoassay support and method of use |
EP0473065A3 (en) * | 1990-08-29 | 1992-08-26 | Abbott Laboratories | Simultaneous assay for detecting two or more analytes |
US5789165A (en) * | 1993-05-10 | 1998-08-04 | Nissui Pharmaceutical Co., Ltd. | Method and reagent for simultaneously assaying one or more ligands in a group of preselected ligands |
EP0627625A1 (de) * | 1993-06-04 | 1994-12-07 | Abbott Laboratories | Immunoassay für Differentialdiagnose |
US5731161A (en) * | 1995-04-24 | 1998-03-24 | Allergan, Inc. | Botulinum toxin antibody detection assay |
US6020122A (en) * | 1995-06-07 | 2000-02-01 | Abbott Laboratories | Hepatitis C virus second envelope (HCV-E2) glycoprotein expression system |
IT1290804B1 (it) * | 1996-08-16 | 1998-12-11 | Abbott Lab | Saggio western blot perfezionato per l'individuazione di anticorpi specifici contro il virus hcmv |
US6680208B1 (en) | 1999-11-19 | 2004-01-20 | Becton, Dickinson And Company | Rapid protein identification using antibody mixtures |
US6933109B2 (en) * | 2000-12-22 | 2005-08-23 | Large Scale Proteomics Corporation | Rapid particle detection |
EP1853696B1 (de) | 2005-02-24 | 2019-04-17 | Life Technologies (Israel) Ltd. | Vorrichtungen, systeme und kits zum elektroblotting sowie verfahren zu ihrer verwendung |
US7749717B2 (en) * | 2006-10-19 | 2010-07-06 | Abbott Laboratories | Methods for the detection and diagnosis of Trypanosoma cruzi infection |
US8075755B2 (en) * | 2007-12-13 | 2011-12-13 | Bio-Rad Laboratories, Inc. | Polymeric sorbent sheets as ion reservoirs for electroblotting |
AU2009233785B2 (en) | 2008-04-11 | 2015-08-20 | Berg Llc | Methods and use of inducing apoptosis in cancer cells |
US20100044229A1 (en) * | 2008-07-11 | 2010-02-25 | Life Technologies Corporation | Electrophoretically Enhanced Detection of Analytes on a Solid Support |
US8715476B2 (en) | 2009-12-11 | 2014-05-06 | Bio-Rad Laboratories, Inc. | Instrument for independent electrotransfer in multiple cassettes |
ES2625406T3 (es) | 2010-03-25 | 2017-07-19 | Oregon Health & Science University | Glicoproteínas de CMV y vectores recombinantes |
PL2691530T3 (pl) | 2011-06-10 | 2019-02-28 | Oregon Health & Science University | Glikoproteiny i rekombinowane wektory CMV |
AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
EP2586461A1 (de) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Von einem eingehüllten Virus abgeleitete Virenpartikel |
EP2679596B1 (de) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 Env-proteinvariante |
EP2877483B1 (de) | 2012-07-25 | 2019-05-15 | Bio-rad Laboratories, Inc. | Gezielte abgabe von reagenzien durch gemusterte übertragungsfolien |
SG11201502782YA (en) | 2012-10-17 | 2015-05-28 | Bio Rad Laboratories | Image capture for large analyte arrays |
US9291596B2 (en) | 2013-02-12 | 2016-03-22 | Pierce Biotechnology, Inc. | Electroblot transfer buffer |
USD738527S1 (en) | 2013-05-28 | 2015-09-08 | Life Technologies Corporation | Electroblotting apparatus |
EP2848937A1 (de) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Verfahren zur Identifizierung neuartiger HIV-1-Immunogene |
US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
EP3069730A3 (de) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4452901A (en) * | 1980-03-20 | 1984-06-05 | Ciba-Geigy Corporation | Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays |
AR231590A1 (es) * | 1981-04-29 | 1984-12-28 | Ciba Geigy Ag | Dispositivo de analisis inmunologico y procedimiento para obtenerlo |
IE58321B1 (en) * | 1984-04-23 | 1993-09-08 | Us Health | Isolation of proteins of HTLV-III, serological detection of antibodies to HTLV-III in sera of patients with aids and pre-aids conditions, and detection of HTLV-III infection bi/immuno-assays using HTLV-III infection by immuno-assays using HTLV-III and its proteins |
ZA855031B (en) * | 1984-08-31 | 1986-02-26 | New York Blood Center Inc | Assay for simultaneous detection of antigen and antibody in given serum |
US4843011A (en) * | 1985-08-01 | 1989-06-27 | Akzo N.V. | Monoclonal antibodies for binding HTLV-III proteins, and cell lines for their production |
CH669265A5 (de) * | 1985-12-18 | 1989-02-28 | Celldynamics Ag | Multiindikator-teststreifen fuer immunologische analysen, ihre herstellung und verwendung. |
US4980279A (en) * | 1986-04-15 | 1990-12-25 | Scripps Clinic And Research Foundation | Cellular fibronectin: polypeptides, anti-polypeptide antibodies and assay methods |
US4816387A (en) * | 1986-06-06 | 1989-03-28 | Bio-Research Laboratories, Inc. | Method for detection of antibodies to HTLV-III and diagnostic test kit useful therewith |
ATE130050T1 (de) * | 1987-07-13 | 1995-11-15 | Verigen Inc | Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern. |
JPH01113663A (ja) * | 1987-10-28 | 1989-05-02 | Eisai Co Ltd | Atlv抗体の測定試薬および測定方法 |
-
1990
- 1990-05-03 AU AU54742/90A patent/AU637097B2/en not_active Ceased
- 1990-05-08 CA CA002016313A patent/CA2016313C/en not_active Expired - Fee Related
- 1990-05-09 JP JP2119648A patent/JP2945074B2/ja not_active Expired - Fee Related
- 1990-05-09 KR KR1019900006519A patent/KR900018680A/ko not_active Application Discontinuation
- 1990-05-09 ES ES90108710T patent/ES2091777T3/es not_active Expired - Lifetime
- 1990-05-09 EP EP90108710A patent/EP0397129B1/de not_active Expired - Lifetime
- 1990-05-09 DE DE69027812T patent/DE69027812T2/de not_active Expired - Fee Related
- 1990-05-09 AT AT90108710T patent/ATE140540T1/de not_active IP Right Cessation
- 1990-12-05 US US07/622,311 patent/US5356772A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5356772A (en) | 1994-10-18 |
EP0397129B1 (de) | 1996-07-17 |
ES2091777T3 (es) | 1996-11-16 |
JP2945074B2 (ja) | 1999-09-06 |
KR900018680A (ko) | 1990-12-22 |
DE69027812D1 (de) | 1996-08-22 |
EP0397129A3 (de) | 1991-11-13 |
JPH0328765A (ja) | 1991-02-06 |
EP0397129A2 (de) | 1990-11-14 |
CA2016313C (en) | 2002-12-31 |
AU637097B2 (en) | 1993-05-20 |
CA2016313A1 (en) | 1990-11-09 |
AU5474290A (en) | 1990-11-15 |
DE69027812T2 (de) | 1997-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE140540T1 (de) | Verfahren zur zurichtung eines verbesserten western-blott-immuntestverfahrens | |
DE3486404D1 (de) | Verfahren und produkte zur feststellung von menschlichem t-zellen-leukämie-virus. | |
SE8704185L (sv) | Nya peptider, artificiella antigener och immunoanalystestsatser | |
NO870412L (no) | Peptider. | |
EA200100943A1 (ru) | Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител | |
DE68923882D1 (de) | Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen. | |
ES2139571T3 (es) | Ensayo de hepatitis c que utiliza antigenos recombinantes. | |
ATE191792T1 (de) | Verfahren zur detektion von hepatitis c | |
DE69033080D1 (de) | Zuwachsfaktorrezeptorgen deriviert von platten des typs oc | |
DE3579856D1 (de) | Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern. | |
DK362287D0 (da) | Method for rapid and sensitive detection of hiv-1 antibodies | |
ES2094124T3 (es) | Ensayo-inmunologico de anticuerpos contra hiv. | |
EP0267622A3 (de) | Verfahren zum Nachweis von Antikörper gegen Anti-Adult-T-Zellen-Leukämie-Virus | |
ATE138078T1 (de) | Analysemethode für infektiöse pferdeanämie-viren (eia-virus) | |
DE3679926D1 (de) | Nachweis von human-t-zellen-leukemievirus des typs-iii. | |
ATE54758T1 (de) | Verfahren zur bestimmung der antikoerper vom herpes-simplex-virus. | |
DE3854665D1 (de) | Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern. | |
DK619984A (da) | Fremgangsmaade og produkter til detektering af humant t-celleleukaemivirus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |